Randomized phase III trial comparing Daunorubicin and ara-C (DA) versus ara-C, Daunorubicin, and Etoposide (ADE) as induction chemotherapy in pediatric acute myeloid leukemia (InPOG-AML-16-01)
Venkatraman Radhakrishnan,
Sameer Bakhshi,
Smita Kayal,
Cherian Thampy,
Ankit Batra,
Praveen Kumar Shenoy,
Hemanth Kumar,
Shilpi Chaudhary,
Swaminathan Rajaraman,
Reema Bisht,
Biswajit Dubashi,
Trivadi S. Ganesan
Affiliations
Venkatraman Radhakrishnan
Presenting Author: Venkatraman Radhakrishnan, Cancer Institute (W.I.A); Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Sameer Bakhshi
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Smita Kayal
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Cherian Thampy
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Ankit Batra
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Praveen Kumar Shenoy
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Hemanth Kumar
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Shilpi Chaudhary
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Swaminathan Rajaraman
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Reema Bisht
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Biswajit Dubashi
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
Trivadi S. Ganesan
Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry
